副肿瘤性钙调蛋白激酶样囊泡相关蛋白(CAMKV)自身免疫性脑炎
研究报道了一种以IgG抗体靶向突触蛋白CAMKV为特征的副肿瘤性自身免疫性脑炎。5例CAMKV-IgG阳性患者中,脑炎表现为亚急性或急性起病,伴精神状态改变、癫痫发作、运动增多等,全部有MRI异常,常见子宫腺癌等肿瘤;接受免疫治疗者均出现初步反应。
要点
- CAMKV-IgG是副肿瘤性自身免疫性脑炎的生物标志物,对免疫治疗有反应。
- 5例患者中4例亚急性起病,全部有精神状态改变,4例有癫痫发作和运动增多。
- 全部患者MRI显示异常,包括内侧颞叶T2高信号等,无钆增强。
核心结论
- CAMKV-IgG是免疫治疗反应性副肿瘤性脑炎的生物标志物,具有颞叶和颞外特征,子宫癌为突出肿瘤关联。
研究设计与样本
- 研究通过人类蛋白微阵列筛查小鼠脑间接免疫荧光 assay 中未分类抗体的血清和脑脊液样本,在5例具有相同大脑免疫荧光染色的患者中鉴定CAMKV为顶级候选抗原。
主要发现
- 5例CAMKV-IgG阳性患者中3例为女性,中位症状 onset 年龄59岁(范围53-74)。
- 脑炎起病亚急性4例、急性1例,表现包括精神状态改变(全部)、癫痫发作(4例)、运动增多(4例)、精神症状(3例)、记忆丧失(2例)和失眠(2例)。
- 辅助检查显示脑脊液淋巴细胞增多(全部4例受检)、脑电图癫痫发作(4例受检中3例),全部患者MRI异常:内侧颞叶T2高信号(全部)、尾状核头T2高信号(3例)、皮质弥散加权高信号(2例),无钆增强。
- 肿瘤包括子宫腺癌(3例,其中2例低分化或神经内分泌分化,均显示CAMKV免疫反应性)、膀胱尿路上皮癌(1例)和非霍奇金淋巴瘤(1例);2例在免疫检查点抑制剂治疗后发生脑炎(阿替利珠单抗1例、帕博利珠单抗1例)。
- 所有接受治疗的患者(4例)对免疫治疗(皮质类固醇4例、IVIG 2例)出现初步反应,但3例死于癌症。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To report an autoimmune paraneoplastic encephalitis characterized by immunoglobulin G (IgG) antibody targeting synaptic protein calmodulin kinase-like vesicle-associated (CAMKV). METHODS: Serum and cerebrospinal fluid (CSF) samples harboring unclassified antibodies on murine brain-based indirect immunofluorescence assay (IFA) were screened by human protein microarray. In 5 patients with identical cerebral IFA staining, CAMKV was identified as top-ranking candidate antigen. Western blots, confocal microscopy, immune-absorption, and mass spectrometry were performed to substantiate CAMKV specificity. Recombinant CAMKV-specific assays (cell-based [fixed and live] and Western blot) provided additional confirmation. RESULTS: Of 5 CAMKV-IgG positive patients, 3 were women (median symptom-onset age was 59 years; range, 53-74). Encephalitis-onset was subacute (4) or acute (1) and manifested with: altered mental status (all), seizures (4), hyperkinetic movements (4), psychiatric features (3), memory loss (2), and insomnia (2). Paraclinical testing revealed CSF lymphocytic pleocytosis (all 4 tested), electrographic seizures (3 of 4 tested), and striking MRI abnormalities in all (mesial temporal lobe T2 hyperintensities [all patients], caudate head T2 hyperintensities [3], and cortical diffusion weighted hyperintensities [2]). None had post-gadolinium enhancement. Cancers were uterine adenocarcinoma (3 patients: poorly differentiated or neuroendocrine-differentiated in 2, both demonstrated CAMKV immunoreactivity), bladder urothelial carcinoma (1), and non-Hodgkin lymphoma (1). Two patients developed encephalitis following immune checkpoint inhibitor cancer therapy (atezolizumab [1], pembrolizumab [1]). All treated patients (4) demonstrated an initial response to immunotherapy (corticosteroids [4], IVIG [2]), though 3 died from cancer. INTERPRETATION: CAMKV-IgG is a biomarker of immunotherapy-responsive paraneoplastic encephalitis with temporal and extratemporal features and uterine cancer as a prominent oncologic association. ANN NEUROL 2024;96:21-33.
引用
- Gilligan M, Lesnick CE, Guo Y, et al. Paraneoplastic Calmodulin Kinase-Like Vesicle-Associated Protein (CAMKV) Autoimmune Encephalitis. Ann Neurol. 2024. PMID: 38634529. doi:10.1002/ana.26943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。